Cr Double-Crane - Crunchbase Company Profile & Funding

Q: Where is Cr Double-Crane's headquarters?

Cr Double-Crane is located in Beijing, Beijing, China.

Overview

Cr Double-Crane

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Cr Double-Crane

CB Rank

3382844

Crane Pharmaceutical is a Pharmaceutical Company.

Founded

obfuscation

Public

Beijing, Beijing, China

10001+

www.dcpc.com/

Health Care

Medical

Pharmaceutical

Details

Legal Name

China Resources Shuanghe Pharmaceutical Co., Ltd.

Also Known As

华润双鹤, 华润双鹤药业股份有限公司, CR Double-Crane

Operating Status

Active

Stock Symbol

SSE:600062

Company Type

For Profit

About the Company

Founded in 1939, China Resources Shuanghe Pharmaceutical Co., Ltd. was originally born in the Taihang Mountain Revolutionary Base. It was named Lihua Pharmaceutical Factory. In 1949, it moved to Beijing, renamed Beijing Pharmaceutical Factory, and developed into a large state-owned chemical. The comprehensive preparation enterprise laid the

foundation of Beijing Hyundai Chemical Pharmaceutical Industry; it was listed on the Shanghai Stock Exchange in 1997 and renamed Shuanghe Pharmaceutical Co., Ltd., and became a cross-regional group based in Beijing and radiating across the country through expansion. In 2010, it entered with the original shareholder Beijing Pharmaceutical Group. Under the name of China Resources Shuanghe Pharmaceutical Co., Ltd., a Fortune 500 company in the world, it is now a pillar enterprise of the chemical tablet platform of China Resources Group.